Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesTopiramate in migraine progression
The Journal of Headache and Pain, 10/20/09
Ruiz L et al. – Increasing evidence shows that migraine, typically considered as an episodic disease, is a chronic and, in some patients, progressive disorder. Among neuromodulators used for migraine prevention, topiramate has a high level of evidence–based efficacy. Recent evidence suggests that topiramate, by reducing migraine frequency and use of acute medication, may prevent the negative progression of migraine. Furthermore, two recently completed multicenter, randomised, placebo–controlled trials have shown that treatment with topiramate 100 mg/day is effective and well tolerated in patients already progressed to chronic migraine and difficult to treat conditions associated with medication–overuse. Topiramate seems to be a preventive treatment, which might be able to act at different levels of the migraine cycle: reduction of frequency in episodic migraine, prevention, and treatment of chronic migraine.
Related Articles
Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting
The Journal of Headache and Pain, 11/10/09
Relevance Score: 81%
Topiramate for Migraine Prevention in a Naturalistic Setting: Results From an Open Label, Flexible Dose Study
Headache: The Journal of Head and Face Pain, 10/07/09
Relevance Score: 81%
A Double-Blind Comparison of OnabotulinumtoxinA (BOTOX) and Topiramate (TOPAMAX) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study
Headache: The Journal of Head and Face Pain, 11/05/09
Relevance Score: 80%
Controversies in migraine
Nurse Prescribing, 10/09/09
Relevance Score: 68%
New drugs for migraine
The Journal of Headache and Pain, 10/05/09
Relevance Score: 68%
Today in Pain Management...keeping you current
Receive free subspecialty "5-minute updates" via email
U.S. Opioid Risk Management Initiatives
Pain: Clinical Updates (IASP’s clinical newsletter), 11/20/09
Effect of Ethanol on the Release of Morphine Sulfate From Oramorph SR Tablets
American Journal of Therapeutics, 11/20/09
Pharmacology of steroids used during epidural steroid injections
Techniques in Regional Anesthesia and Pain Management, 11/20/09
Sponsor
Article Search
Sponsor